Cytotoxic T lymphocyte antigen-4 down-regulates T helper 1 cells by increasing STAT3 expression in a

来源 :中国免疫学会第十届全国免疫学学术大会 | 被引量 : 0次 | 上传用户:scholar165
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Objective: The purpose of this study was to ascertain if cytotoxic T lymphocyte antigen-4 (CTLA-4) playing an important role in the occurrence and progress of acute graft-versus-host disease (GVHD).
其他文献
背景:近年来的研究发现,核苷酸作为一种危险信号分子对激活巨噬细胞、调节炎症具有十分重要的作用。而对胞外核苷酸ADP在细菌感染过程中的功能及作用机制尚未有详细报道。方法:为此本课题首先建立了小鼠体内、外的细菌感染模型,并对细菌感染过程中胞外ADP的释放、受体表达以及ADP的抗菌作用进行了初步评价。
Microbial exopolysaccharides (EPSs), long-chain polysaccharides released by a variety of organisms, have gained considerable attention for their potential in multiple disease treatments.
Rationale: Severe combined immunodeficiency (SCID), a rare PID, is poorly characterized in China.We retrospectively reviewed patients with SCID refered to our hospital from 2004 to 2013, and summarize
Objective: Mutations in gone ZBTB24 lead to autosomal-recessive immunodeficiency, centromeric instability, and facial anomalies (ICF) syndrome in some patients.
Background: Programmed cell death 4 (PDCD4) is a newly defined transcriptional and translational inhibitor, and tumor suppressor.
Human gingival tissue-derived mesenchymal stem cells (GMSCs) are a convenient source of MSCs that have been shown to treat autoimmunc disease.
Background: We previously demonstrated that atorvastatin induced immature dendritic cells (DCs) derived from spleen in vitro.
Background aims.Mesenchymal stem cells (MSCs) and regulatory T cells (Treg) have been successfully used in treating autoimmune diseases accompanied by abundant inflammatory cytokines such as IFN-γ and
Aim: Blockade of the protein-protein interaction between the transmembrane programmed cell death 1 protein (PD-1) and its ligand PD-L1 emerges as a promising immunotherapy for treating cancer.
目的:建立小鼠原位气管移植模型,研究Th17细胞对移植物的影响。方法:供受体按体质量配对后随机分为6组,同系移植组:C57BL/6→C57BL/6 (n=10);同种移植组:BALB/c→C57BL/6 (n=10);IL-17AAb组:BALB/c→C57BL/6,注射anti-IL-17A抗体(n=10);IL-6 Ab组:BALB/c→C57BL/6,注射anti-IL-6抗体(n=10);